Clinical Trials Browser

Phase 1 × INDUSTRY × pixantrone × Clear all

NCT01632436 2023-10-02

Hepatic

Phase 1 Withdrawn

Neoplasm Metastasis

NCT02800889 2020-01-29

Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer

Phase 1 Withdrawn

Lymphoma, Recurrence

NCT00060684 2015-01-19

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Phase 1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell